Kenvue reported third-quarter 2026 net sales growth of 3.2%, while organic sales grew 2.9%. The consumer-health company also reported diluted earnings per share of $0.22, compared with $0.21 a year earlier. Adjusted diluted EPS, a non-GAAP measure, was $0.29 versus $0.28.
The company said it will not provide forward-looking guidance because its transaction with Kimberly-Clark is pending. That is a status statement, not evidence that the transaction has closed.
Key reported figures
| Measure | Q3 2026 | Comparison / basis | Primary source |
|---|---|---|---|
| Net sales | Up 3.2% | Year on year | SEC-filed release |
| Organic sales | Up 2.9% | Excludes foreign-exchange and acquisition/divestiture effects under Kenvue’s definition | SEC-filed release |
| Diluted EPS | $0.22 | Reported GAAP measure; prior year $0.21 | SEC-filed release |
| Adjusted diluted EPS | $0.29 | Non-GAAP measure; prior year $0.28 | SEC-filed release |
| Forward guidance | Not provided | Company cited pending Kimberly-Clark transaction | SEC-filed release |
Source checked 1 November 2026: Kenvue’s SEC-filed Q3 release. Adjusted EPS is supplied by the company and should be read alongside the reported figure and its reconciliation.
Why the distinction matters
Reported EPS follows U.S. GAAP. Adjusted EPS excludes items chosen under the company’s non-GAAP methodology, so it is not interchangeable with reported EPS. Kenvue’s release says its adjustments include, among other items, restructuring and transaction-related costs.
What to watch
Readers should watch future disclosures on the pending Kimberly-Clark transaction and any return of formal guidance. Neither the sales result nor the company’s description of the transaction establishes a closing date or future financial outcome.
CapKet reporting prepared with AI assistance and checked against the official primary record. Information only; not investment advice.
Cross-check: Kenvue Q3 2026 Form 10-Q filed with the SEC was reviewed alongside the release. Both are official primary records; the filing provides the detailed quarterly record, while the release supplies the current-period summary and disclosed adjusted measures or outlook where applicable.
Recorded source observation: . This is a source-check timestamp, not a market quote or a new article update.